HEADER HYDROLASE/HYDROLASE INHIBITOR 05-MAR-03 1OPH TITLE NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: ALPHA-1-ANTITRYPSIN PRECURSOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ALPHA-1-ANTITRYPSIN (RESIDUES 26-418); COMPND 5 SYNONYM: ALPHA-1 PROTEASE INHIBITOR, ALPHA-1- ANTIPROTEINASE, COMPND 6 PRO0684/PRO2209; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: TRYPSINOGEN, CATIONIC PRECURSOR; COMPND 11 CHAIN: B; COMPND 12 SYNONYM: BETA-TRYPSIN, FRAGMENT; COMPND 13 EC: 3.4.21.4; COMPND 14 ENGINEERED: YES; COMPND 15 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 TISSUE: BLOOD; SOURCE 6 GENE: SERPINA1 OR PI OR AAT; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: SG13009; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: SG13009; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PQE30; SOURCE 13 MOL_ID: 2; SOURCE 14 ORGANISM_SCIENTIFIC: BOS TAURUS; SOURCE 15 ORGANISM_COMMON: CATTLE; SOURCE 16 ORGANISM_TAXID: 9913; SOURCE 17 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 19 EXPRESSION_SYSTEM_STRAIN: SG13009; SOURCE 20 EXPRESSION_SYSTEM_CELL_LINE: SG13009; SOURCE 21 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 22 EXPRESSION_SYSTEM_PLASMID: PQE60 KEYWDS SERINE PROTEINASE INHIBITOR, MICHAELIS-LIKE COMPLEX, SERPIN, ALPHA-1 KEYWDS 2 ANTITRYPSIN, TRYPSIN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.DEMENTIEV,M.SIMONOVIC,K.VOLZ,P.G.GETTINS REVDAT 6 16-AUG-23 1OPH 1 REMARK REVDAT 5 27-OCT-21 1OPH 1 SEQADV REVDAT 4 24-FEB-09 1OPH 1 VERSN REVDAT 3 13-JAN-04 1OPH 1 JRNL REVDAT 2 30-SEP-03 1OPH 1 JRNL REVDAT 1 05-AUG-03 1OPH 0 JRNL AUTH A.DEMENTIEV,M.SIMONOVIC,K.VOLZ,P.G.GETTINS JRNL TITL CANONICAL INHIBITOR-LIKE INTERACTIONS EXPLAIN REACTIVITY OF JRNL TITL 2 ALPHA1-PROTEINASE INHIBITOR PITTSBURGH AND ANTITHROMBIN WITH JRNL TITL 3 PROTEINASES JRNL REF J.BIOL.CHEM. V. 278 37881 2003 JRNL REFN ISSN 0021-9258 JRNL PMID 12860985 JRNL DOI 10.1074/JBC.M305195200 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 32771 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3277 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.41 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 92.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 4567 REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE : 0.2540 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.90 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 362 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.013 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4542 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 377 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.00 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -8.51000 REMARK 3 B22 (A**2) : 19.34000 REMARK 3 B33 (A**2) : -10.83000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.08000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.24 REMARK 3 ESD FROM SIGMAA (A) : 0.26 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.31 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.300 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.790 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.330 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.180 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.170 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.150 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 49.09 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.PARAM REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1OPH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAR-03. REMARK 100 THE DEPOSITION ID IS D_1000018534. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-AUG-02; 27-AUG-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0; 100.0 REMARK 200 PH : 8.30 REMARK 200 NUMBER OF CRYSTALS USED : 2 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y; Y REMARK 200 RADIATION SOURCE : APS; APS REMARK 200 BEAMLINE : 22-ID; 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL; NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M; M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000; 1.0000 REMARK 200 MONOCHROMATOR : SI 220; SI 220 REMARK 200 OPTICS : NULL; NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD; CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH; MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 32771 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 19.20 REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 20.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.3 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.28900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.750 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH; SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1QLP AND 1EJM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M TRI-K-CITRATE, 17.5% PEG 3350, REMARK 280 2% GLYCEROL, PH 8.30, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 66.11500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.16000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 66.11500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 31.16000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1350 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5820 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 45130 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 97.89263 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 92.72648 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ASP A 2 REMARK 465 PRO A 3 REMARK 465 GLN A 4 REMARK 465 GLY A 5 REMARK 465 ASP A 6 REMARK 465 ALA A 7 REMARK 465 ALA A 8 REMARK 465 GLN A 9 REMARK 465 LYS A 10 REMARK 465 THR A 11 REMARK 465 ASP A 12 REMARK 465 THR A 13 REMARK 465 SER A 14 REMARK 465 HIS A 15 REMARK 465 HIS A 16 REMARK 465 ASP A 17 REMARK 465 GLN A 18 REMARK 465 ASP A 19 REMARK 465 PHE B -4 REMARK 465 ILE B -3 REMARK 465 PHE B -2 REMARK 465 LEU B -1 REMARK 465 ALA B 0 REMARK 465 LEU B 1 REMARK 465 LEU B 2 REMARK 465 GLY B 3 REMARK 465 ALA B 4 REMARK 465 ALA B 5 REMARK 465 VAL B 6 REMARK 465 ALA B 7 REMARK 465 PHE B 8 REMARK 465 PRO B 9 REMARK 465 VAL B 10 REMARK 465 ASP B 11 REMARK 465 ASP B 12 REMARK 465 ASP B 13 REMARK 465 ASP B 14 REMARK 465 LYS B 15 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 94 CG CD OE1 OE2 REMARK 470 LYS A 135 CG CD CE NZ REMARK 470 LYS A 136 CG CD CE NZ REMARK 470 LYS A 155 CG CD CE NZ REMARK 470 GLN A 156 CG CD OE1 NE2 REMARK 470 LYS A 163 CG CD CE NZ REMARK 470 GLN A 166 CG CD OE1 NE2 REMARK 470 LYS A 168 CG CD CE NZ REMARK 470 LYS A 174 CG CD CE NZ REMARK 470 GLU A 175 CG CD OE1 OE2 REMARK 470 ARG A 178 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 193 CG CD CE NZ REMARK 470 LYS A 201 CG CD CE NZ REMARK 470 LYS A 233 CG CD CE NZ REMARK 470 GLN B 240 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OXT LYS A 394 O HOH A 734 1.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 51 117.20 -163.55 REMARK 500 GLU A 86 -24.78 -143.89 REMARK 500 ASP A 107 73.30 -104.77 REMARK 500 ALA A 347 40.13 175.97 REMARK 500 ALA A 348 84.85 -49.36 REMARK 500 SER B 37 44.07 -142.16 REMARK 500 ASP B 71 -78.29 -137.24 REMARK 500 ASN B 115 -158.69 -157.14 REMARK 500 SER B 214 -70.73 -120.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1OO8 RELATED DB: PDB REMARK 900 RELATED ID: 1QLP RELATED DB: PDB REMARK 900 RELATED ID: 1EJM RELATED DB: PDB DBREF 1OPH A 1 394 UNP P01009 A1AT_HUMAN 26 418 DBREF 1OPH B -4 245 UNP P00760 TRY1_BOVIN 1 243 SEQADV 1OPH MET A 1 UNP P01009 INITIATING METHIONINE SEQADV 1OPH LEU A 51 UNP P01009 PHE 75 ENGINEERED MUTATION SEQADV 1OPH ALA A 59 UNP P01009 THR 83 ENGINEERED MUTATION SEQADV 1OPH ALA A 68 UNP P01009 THR 92 ENGINEERED MUTATION SEQADV 1OPH GLY A 70 UNP P01009 ALA 94 ENGINEERED MUTATION SEQADV 1OPH SER A 232 UNP P01009 CYS 256 ENGINEERED MUTATION SEQADV 1OPH ARG A 358 UNP P01009 MET 382 ENGINEERED MUTATION SEQADV 1OPH ILE A 374 UNP P01009 MET 398 ENGINEERED MUTATION SEQADV 1OPH ALA A 381 UNP P01009 SER 405 ENGINEERED MUTATION SEQADV 1OPH ARG A 387 UNP P01009 LYS 411 ENGINEERED MUTATION SEQADV 1OPH ALA B 195 UNP P00760 SER 197 ENGINEERED MUTATION SEQRES 1 A 394 MET ASP PRO GLN GLY ASP ALA ALA GLN LYS THR ASP THR SEQRES 2 A 394 SER HIS HIS ASP GLN ASP HIS PRO THR PHE ASN LYS ILE SEQRES 3 A 394 THR PRO ASN LEU ALA GLU PHE ALA PHE SER LEU TYR ARG SEQRES 4 A 394 GLN LEU ALA HIS GLN SER ASN SER THR ASN ILE LEU PHE SEQRES 5 A 394 SER PRO VAL SER ILE ALA ALA ALA PHE ALA MET LEU SER SEQRES 6 A 394 LEU GLY ALA LYS GLY ASP THR HIS ASP GLU ILE LEU GLU SEQRES 7 A 394 GLY LEU ASN PHE ASN LEU THR GLU ILE PRO GLU ALA GLN SEQRES 8 A 394 ILE HIS GLU GLY PHE GLN GLU LEU LEU ARG THR LEU ASN SEQRES 9 A 394 GLN PRO ASP SER GLN LEU GLN LEU THR THR GLY ASN GLY SEQRES 10 A 394 LEU PHE LEU SER GLU GLY LEU LYS LEU VAL ASP LYS PHE SEQRES 11 A 394 LEU GLU ASP VAL LYS LYS LEU TYR HIS SER GLU ALA PHE SEQRES 12 A 394 THR VAL ASN PHE GLY ASP THR GLU GLU ALA LYS LYS GLN SEQRES 13 A 394 ILE ASN ASP TYR VAL GLU LYS GLY THR GLN GLY LYS ILE SEQRES 14 A 394 VAL ASP LEU VAL LYS GLU LEU ASP ARG ASP THR VAL PHE SEQRES 15 A 394 ALA LEU VAL ASN TYR ILE PHE PHE LYS GLY LYS TRP GLU SEQRES 16 A 394 ARG PRO PHE GLU VAL LYS ASP THR GLU GLU GLU ASP PHE SEQRES 17 A 394 HIS VAL ASP GLN VAL THR THR VAL LYS VAL PRO MET MET SEQRES 18 A 394 LYS ARG LEU GLY MET PHE ASN ILE GLN HIS SER LYS LYS SEQRES 19 A 394 LEU SER SER TRP VAL LEU LEU MET LYS TYR LEU GLY ASN SEQRES 20 A 394 ALA THR ALA ILE PHE PHE LEU PRO ASP GLU GLY LYS LEU SEQRES 21 A 394 GLN HIS LEU GLU ASN GLU LEU THR HIS ASP ILE ILE THR SEQRES 22 A 394 LYS PHE LEU GLU ASN GLU ASP ARG ARG SER ALA SER LEU SEQRES 23 A 394 HIS LEU PRO LYS LEU SER ILE THR GLY THR TYR ASP LEU SEQRES 24 A 394 LYS SER VAL LEU GLY GLN LEU GLY ILE THR LYS VAL PHE SEQRES 25 A 394 SER ASN GLY ALA ASP LEU SER GLY VAL THR GLU GLU ALA SEQRES 26 A 394 PRO LEU LYS LEU SER LYS ALA VAL HIS LYS ALA VAL LEU SEQRES 27 A 394 THR ILE ASP GLU LYS GLY THR GLU ALA ALA GLY ALA MET SEQRES 28 A 394 PHE LEU GLU ALA ILE PRO ARG SER ILE PRO PRO GLU VAL SEQRES 29 A 394 LYS PHE ASN LYS PRO PHE VAL PHE LEU ILE ILE GLU GLN SEQRES 30 A 394 ASN THR LYS ALA PRO LEU PHE MET GLY ARG VAL VAL ASN SEQRES 31 A 394 PRO THR GLN LYS SEQRES 1 B 243 PHE ILE PHE LEU ALA LEU LEU GLY ALA ALA VAL ALA PHE SEQRES 2 B 243 PRO VAL ASP ASP ASP ASP LYS ILE VAL GLY GLY TYR THR SEQRES 3 B 243 CYS GLY ALA ASN THR VAL PRO TYR GLN VAL SER LEU ASN SEQRES 4 B 243 SER GLY TYR HIS PHE CYS GLY GLY SER LEU ILE ASN SER SEQRES 5 B 243 GLN TRP VAL VAL SER ALA ALA HIS CYS TYR LYS SER GLY SEQRES 6 B 243 ILE GLN VAL ARG LEU GLY GLU ASP ASN ILE ASN VAL VAL SEQRES 7 B 243 GLU GLY ASN GLU GLN PHE ILE SER ALA SER LYS SER ILE SEQRES 8 B 243 VAL HIS PRO SER TYR ASN SER ASN THR LEU ASN ASN ASP SEQRES 9 B 243 ILE MET LEU ILE LYS LEU LYS SER ALA ALA SER LEU ASN SEQRES 10 B 243 SER ARG VAL ALA SER ILE SER LEU PRO THR SER CYS ALA SEQRES 11 B 243 SER ALA GLY THR GLN CYS LEU ILE SER GLY TRP GLY ASN SEQRES 12 B 243 THR LYS SER SER GLY THR SER TYR PRO ASP VAL LEU LYS SEQRES 13 B 243 CYS LEU LYS ALA PRO ILE LEU SER ASP SER SER CYS LYS SEQRES 14 B 243 SER ALA TYR PRO GLY GLN ILE THR SER ASN MET PHE CYS SEQRES 15 B 243 ALA GLY TYR LEU GLU GLY GLY LYS ASP SER CYS GLN GLY SEQRES 16 B 243 ASP ALA GLY GLY PRO VAL VAL CYS SER GLY LYS LEU GLN SEQRES 17 B 243 GLY ILE VAL SER TRP GLY SER GLY CYS ALA GLN LYS ASN SEQRES 18 B 243 LYS PRO GLY VAL TYR THR LYS VAL CYS ASN TYR VAL SER SEQRES 19 B 243 TRP ILE LYS GLN THR ILE ALA SER ASN FORMUL 3 HOH *377(H2 O) HELIX 1 1 PRO A 21 SER A 45 1 25 HELIX 2 2 SER A 53 SER A 65 1 13 HELIX 3 3 LEU A 66 ALA A 68 5 3 HELIX 4 4 LYS A 69 LEU A 80 1 12 HELIX 5 5 PRO A 88 ASN A 104 1 17 HELIX 6 6 VAL A 127 LEU A 137 1 11 HELIX 7 7 ASP A 149 THR A 165 1 17 HELIX 8 8 GLU A 199 THR A 203 5 5 HELIX 9 9 LYS A 259 LEU A 267 1 9 HELIX 10 10 THR A 268 ASN A 278 1 11 HELIX 11 11 LEU A 299 LEU A 306 1 8 HELIX 12 12 THR A 309 SER A 313 5 5 HELIX 13 13 GLY A 349 LEU A 353 5 5 HELIX 14 14 ALA B 55 TYR B 59 5 5 HELIX 15 15 SER B 164 TYR B 172 1 9 HELIX 16 16 TYR B 234 SER B 244 1 11 SHEET 1 A12 ILE A 50 PHE A 52 0 SHEET 2 A12 PRO A 382 VAL A 388 -1 N MET A 385 O PHE A 52 SHEET 3 A12 PHE A 370 GLU A 376 -1 O PHE A 370 N VAL A 388 SHEET 4 A12 ALA A 248 PRO A 255 -1 O THR A 249 N ILE A 375 SHEET 5 A12 SER A 237 LEU A 245 -1 O TRP A 238 N LEU A 254 SHEET 6 A12 LYS A 193 TRP A 194 -1 O LYS A 193 N LEU A 245 SHEET 7 A12 SER A 237 LEU A 245 -1 N LEU A 245 O LYS A 193 SHEET 8 A12 THR A 214 SER A 232 -1 O ASN A 228 N LEU A 241 SHEET 9 A12 GLU A 204 ASP A 211 -1 O GLU A 204 N MET A 220 SHEET 10 A12 THR A 214 SER A 232 -1 O THR A 214 N ASP A 211 SHEET 11 A12 ARG A 282 PRO A 289 -1 O ARG A 282 N PHE A 227 SHEET 12 A12 GLU A 363 LYS A 365 1 O VAL A 364 N HIS A 287 SHEET 1 B 5 GLU A 141 VAL A 145 0 SHEET 2 B 5 LEU A 112 SER A 121 1 O ASN A 116 N GLU A 141 SHEET 3 B 5 PHE A 182 LYS A 191 -1 O ALA A 183 N PHE A 119 SHEET 4 B 5 LYS A 331 ILE A 340 1 O LYS A 331 N LEU A 184 SHEET 5 B 5 LEU A 291 ASP A 298 -1 O LEU A 291 N ILE A 340 SHEET 1 C12 ALA A 355 PRO A 357 0 SHEET 2 C12 LYS B 204 SER B 217 -1 O GLY B 216 N ILE A 356 SHEET 3 C12 PRO B 198 CYS B 201 -1 O VAL B 199 N GLN B 210 SHEET 4 C12 GLN B 135 GLY B 140 -1 N LEU B 137 O VAL B 200 SHEET 5 C12 LYS B 156 PRO B 161 -1 N LYS B 156 O GLY B 140 SHEET 6 C12 TYR B 20 THR B 21 -1 O TYR B 20 N CYS B 157 SHEET 7 C12 LYS B 156 PRO B 161 -1 N CYS B 157 O TYR B 20 SHEET 8 C12 GLN B 135 GLY B 140 -1 N CYS B 136 O ALA B 160 SHEET 9 C12 PRO B 198 CYS B 201 -1 O PRO B 198 N SER B 139 SHEET 10 C12 LYS B 204 SER B 217 -1 O LYS B 204 N CYS B 201 SHEET 11 C12 GLY B 226 LYS B 230 -1 N VAL B 227 O TRP B 215 SHEET 12 C12 MET B 180 ALA B 183 -1 O PHE B 181 N TYR B 228 SHEET 1 D 7 GLN B 30 ASN B 34 0 SHEET 2 D 7 HIS B 40 ASN B 48 -1 N PHE B 41 O LEU B 33 SHEET 3 D 7 TRP B 51 SER B 54 -1 O TRP B 51 N ILE B 47 SHEET 4 D 7 MET B 104 LEU B 108 -1 O MET B 104 N SER B 54 SHEET 5 D 7 GLN B 81 VAL B 90 -1 N SER B 86 O LYS B 107 SHEET 6 D 7 GLN B 64 LEU B 67 -1 N VAL B 65 O ILE B 83 SHEET 7 D 7 GLN B 30 ASN B 34 -1 O SER B 32 N ARG B 66 SSBOND 1 CYS B 22 CYS B 157 1555 1555 2.04 SSBOND 2 CYS B 42 CYS B 58 1555 1555 2.03 SSBOND 3 CYS B 128 CYS B 232 1555 1555 2.04 SSBOND 4 CYS B 136 CYS B 201 1555 1555 2.04 SSBOND 5 CYS B 168 CYS B 182 1555 1555 2.04 SSBOND 6 CYS B 191 CYS B 220 1555 1555 2.04 CRYST1 132.230 62.320 98.880 90.00 110.32 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007563 0.000000 0.002800 0.00000 SCALE2 0.000000 0.016046 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010784 0.00000